GLP-TZ is a dual GIP (Glucose dependent insulinotropic polypeptide) and GLP-1 (Glucagon like peptide 1) receptor agonist used to treat Type 2 Diabetes and Weight management when lower doses are not sufficient enough to deal with such conditions. Tirzepatide binds and activates 2 gut hormone receptors simultaneously. It may work by enhancing glucose dependent first phase insulin secretion after meals, improves insulin sensitivity in adipocytes and may acts on hypothalamus to reduce appetite.
Key Features
| About | |
| Drug Class | Antihyperglycemic agent |
| Subclass | Dual GIP/GLP-1 receptor agonist |
| Active ingredient | Tirzepatide |
| GLP-TZ | |
| Composition | Active ingredients
Tirzepatide Inactive ingredients: Sterile water for injection Bacteriostatic water with 0.9% benzyl alcohol Hydrochloric acid Sodium hydroxide Benzyl alcohol Phenol Metacresol in multi-dose vial |
| Packaging Type | Multi-dose Prefilled vial injector |
| Pack Size | 1 vial |
| Dosage | 10 mg |
| Active ingredients | Tirzepatide |
| Shelf Life | Two years refrigerated for unopened vial. |
| Usages | Weight Management & Type 2 Diabetes |
How does GLP-TZ work?
- It may activate GIP and GLP-1 receptors, GIP boost glucose dependent insulin and may reduce appetite, whereas GLP-1 increases insulin, suppress glucagon, and may slows gastric emptying.
- Blood sugar gets in control by increasing insulin release only when glucose is high and cuts liver glucose output.
- It may act on brains hunger centers to reduce cravings and food intake.
Usage
- It can used in treating Type 2 diabetes only it does not deal with Type 1 Diabetes.
- Chronic weight management in adults
Dosage
- Patient must be on 10 mg weekly at least for 4 weeks and in well tolerated manner.
- Jumping from 10 mg to 20 mg can cause severe side effects like vomiting, dehydration, and malnutrition.
Side effects
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Dyspepsia
- Abdominal pain
- Pancreatitis
- Gallbladder disease
- Acute kidney injury from dehydration
- Severe gastroparesis
- Hypersensitivity
- Hypoglycaemia
Interactions
- Oral meds may delay gastric emptying, it may impact absorption. Take narrow therapeutic index orals 1 hr before injection.
- Insulin Sulfonylureas, it may increase the risk of hypoglycaemia.
- Oral contraceptives may reduce the effectiveness of meds due to delayed absorption. In such situation backup method for 4 weeks after starting/ increasing dose can be used.
- Warfarin, it also interacts adversely
- Alcohol consumption may increase the risk of side effects like nausea, increases pancreatitis risk.
Pharmacokinetics
- Half-life is about 5 days, supports once-weekly dosing.
- Tmax is about 8-72 hours to reach peak plasma concentration, usually 24-48 hours post injection.
- Peak concentration will be 2.6 times faster, increasing side effects risk.
Precautions
- Prior history of pancreatitis or severe GI disease should avoid taking such medications.
- The one with Gallbladder disease should also avoid taking such medications.
- Diabetic retinopathy, here rapid glucose lowering may get worsen.
- Renal impairment, may increase dehydration rusk with GI side effects.
- If symptoms like Suicidal behaviour & ideation can be seen then should avoid taking such medications.
- It can be refrigerated at 2-8 °C but do not freeze.
Conclusion
GLP-TZ is a dual GIP (Glucose dependent insulinotropic polypeptide) and GLP-1 (Glucagon like peptide 1) receptor agonist used to treat Type 2 Diabetes and Weight management when lower doses are not sufficient enough to deal with such conditions. Tirzepatide binds and activates 2 gut hormone receptors simultaneously. It may work by enhancing glucose dependent first phase insulin secretion after meals, improves insulin sensitivity in adipocytes and may acts on hypothalamus to reduce appetite. It may show some side effects to avoid such risk of interactions and side effects need to consult a healthcare provider.
Related Research Peptides
You may also explore Retatrutide (RT10 & RT20), Semax 10 mg, Cagrilintide (CAG), and MOTS-C peptides available at Zycare Peptides.
FAQs
For what purpose GLP-TZ is formulated?
Tirzepatide 10 mg is formulated in treating Type 2 Diabetes and Weight management.
How does GLP-TZ work?
Tirzepatide 10 mg may work by enhancing glucose dependent first phase insulin secretion after meals, improves insulin sensitivity in adipocytes and may acts on hypothalamus to reduce appetite.
What can be the possible side effects of GLP-TZ?
The possible side effects of Tirzepatide 10 mg can be vomiting, constipation, dyspepsia, abdominal pain, pancreatitis, gallbladder disease, acute kidney injury from dehydration and severe gastroparesis.
Who should avoid GLP-TZ?
Pregnant Womens, and also the one with medical conditions like pancreatitis, diabetic retinopathy should avoid taking such medications.
Can GLP-TZ can be taken weekly?
Yes Tirzepatide 10 mg can be taken weekly.
Andrew S. –
I’ve been using GLP-TZ as part of my wellness routine and have been impressed with the consistency. It fits easily into my schedule and has been a great addition to my health goals.